Publications by authors named "Richard J Farrell"

Claim this Profile
S
Sociodemographic variables as predictors of adverse outcome in SARS-CoV-2 infection: an Irish hospital experience.
Richard J Farrell, Rhea O'Regan, Eoghan O'Neill, Grainne Bowens, Anne Maclellan

Ir J Med Sci· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologics beyond Anti-TNF Agents for Ulcerative Colitis - Efficacy, Safety, and Cost?
Richard J Farrell

N Engl J Med· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic assessment of inflammatory bowel disease: colonoscopy/esophagogastroduodenoscopy.
Grace Chan, David S Fefferman, Richard J Farrell

Gastroenterol Clin North Am· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravenous, contrast-enhanced MR colonography using air as endoluminal contrast agent: impact on colorectal polyp detection.
Aoife N Keeling, Martina M Morrin, Charles McKenzie, Richard J Farrell, Sunil G Sheth

Eur J Radiol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parallel imaging enhanced MR colonography using a phantom model.
Martina M Morrin, Ivan Pedrosa, Charles A McKenzie, Richard J Farrell, Nicolas Bloch

J Magn Reson Imaging· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A.
Claribel P Taylor, Sanjeev Tummala, Deborah Molrine, Lisa Davidson, Richard J Farrell

Vaccine· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CT colonography in 546 patients with incomplete colonoscopy.
Laurian Copel, Jacob Sosna, Jonathan B Kruskal, Vassilios Raptopoulos, Richard J Farrell

Radiology· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impotent immune system: an underlying problem in Crohn's disease.
Alan C Moss, Richard J Farrell

Gastroenterology· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review.
Mohammad Azam, Maire Buckley, Richard J Farrell

Gastroenterol Hepatol (N Y)· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances in the understanding of celiac disease: therapeutic implications for the management of pediatric patients.
John H Kwon, Richard J Farrell

Paediatr Drugs· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infliximab for induction and maintenance therapy for ulcerative colitis.
Alan C Moss, Richard J Farrell

Gastroenterology· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphoma risk with azathioprine/6-MP therapy-read beyond the headlines.
Alan C Moss, Richard J Farrell

Gastroenterology· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From SNPs to haplotypes: unraveling the role of MDR1 in IBD.
Seema Maroo, Richard J Farrell

Inflamm Bowel Dis· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adding fuel to the fire: GM-CSF for active Crohn's disease.
Alan C Moss, Richard J Farrell

Gastroenterology· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The risk of lymphoma in the treatment of inflammatory bowel disease with immunosuppressive agents.
John H Kwon, Richard J Farrell

Crit Rev Oncol Hematol· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity of biological agents in inflammatory bowel disease.
David S Fefferman, Richard J Farrell

Inflamm Bowel Dis· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infant gluten and celiac disease: too early, too late, too much, too many questions.
Richard J Farrell

JAMA· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice.
David S Fefferman, Richard J Farrell

Clin Gastroenterol Hepatol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smoking and immunomodulators do not influence the response or duration of response to infliximab in Crohn's disease.
David S Fefferman, Parag J Lodhavia, Mazen Alsahli, Kenneth R Falchuk, Mark A Peppercorn, Richard J Farrell

Inflamm Bowel Dis· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Making sense of antisense: ISIS 2302 (alicaforsen) in the treatment of pouchitis. An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule-1, in the treatment of chronic, unremitting pouchits.
David S Fefferman, Richard J Farrell

Inflamm Bowel Dis· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of early surgery for Crohn's disease: implications for early treatment strategies.
Bruce E Sands, Joanne E Arsenault, Michael J Rosen, Mazen Alsahli, Laurence Bailen, Richard J Farrell

Am J Gastroenterol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Celiac disease.
Daniel Leffler, Sumona Saha, Richard J Farrell

Am J Manag Care· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New technology for endoscopic retrograde cholangiopancreatography: improving safety, success, and efficiency.
Richard J Farrell, Douglas A Howell, Douglas K Pleskow

Gastrointest Endosc Clin N Am· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colorectal neoplasms: role of intravenous contrast-enhanced CT colonography.
Jacob Sosna, Martina M Morrin, Jonathan B Kruskal, Richard J Farrell, Imad Nasser

Radiology· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor for ulcerative colitis.
Richard J Farrell

N Engl J Med· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis